The Value of Ga-68-PSMA-PET/CT as a Gatekeeper for Ra-223-Dichloride Therapy

被引：0
|
作者：
Bode, A. [1 ]
Rahbar, K. [1 ]
Konnert, J. [1 ]
Boegemann, M. [1 ]
Stegger, L. [1 ]
机构：
[1] Univ Hosp Munster, Munster, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP455
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [1] Benefit of 68Ga-PSMA-PET/CT in Patients Considered for 223Ra-Dichloride Therapy
    Bode, Axel
    Rahbar, Kambiz
    Konnert, Julia
    Boegemann, Martin
    Stegger, Lars
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : 951 - 952
  • [2] Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
    Braeuer, Axel
    Rahbar, Kambiz
    Konnert, Julia
    Boegemann, Martin
    Stegger, Lars
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2017, 56 (01): : 14 - 22
  • [3] Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma
    Christian H. Pfob
    Ilham Karimov
    Moritz Jesinghaus
    Alexander Novotny
    Wolfgang A. Weber
    Matthias Eiber
    Benedikt Feuerecker
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1041 - 1041
  • [4] Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma
    Pfob, Christian H.
    Karimov, Ilham
    Jesinghaus, Moritz
    Novotny, Alexander
    Weber, Wolfgang A.
    Eiber, Matthias
    Feuerecker, Benedikt
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (04) : 1041 - 1041
  • [5] 68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept
    Ahmadzadehfar, Hojjat
    Azgomi, Kambiz
    Hauser, Stefan
    Wei, Xiao
    Yordanova, Anna
    Gaertner, Florian C.
    Kuerpig, Stefan
    Strunk, Holger
    Essler, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 438 - 444
  • [6] A new clinical setting: 68Ga-PSMA PET/CT after Radium-223-Dichloride as therapy assessment and selection for PSMA-RLT
    Ghedini, P.
    Rizzini, E. Lodi
    Lima, G.
    Monari, F.
    Morganti, A.
    Massari, F.
    Ardizzoni, A.
    Castellucci, P.
    Kratochwil, C.
    Haberkorn, U.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S128 - S129
  • [7] Reliably distinguish between malignant and benign pancreatic tumors with Ga-68-PSMA-PET/CT
    Krome, Susanne
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2022, 194 (02): : 132 - 133
  • [8] Hematological toxicity of Ra-223-dichloride therapy in dependance of bone marrow reserve
    Schueler, W.
    Marx, M.
    Zuhayra, M.
    Jueptner, M.
    Ranjan, J.
    Zhao, Y.
    Luetzen, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S524 - S525
  • [9] 68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer
    de Jong, Anouk C.
    Segbers, Marcel
    Ling, Sui Wai
    Graven, Laura H.
    Mehra, Niven
    Hamberg, Paul
    Brabander, Tessa
    de Wit, Ronald
    van der Veldt, Astrid A. M.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1556 - 1562
  • [10] Prognostic Value of Discordance Between 68Ga-PSMA PET/CT and 99mTc-HDP SPECT/CT Bone Scintigraphy in Metastatic Prostate Cancer Patients Treated with 223Ra-Dichloride
    Plouznikoff, N.
    Artigas, C.
    Gil, T.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S648 - S648
12345